gutaquest, thanks for your post. It appears that a substantial order could be filled quite quickly, at least for the synDNA part. As to delivery of completed vaccines, that looks to be another matter. The business plan I envision is for CYGX to make the synDNA and then have Aldevron market and distribute the goods to the maker of the vaccines, whether it be a country like China or a prime source drug maker like Powdermed. That would get revenue coming sooner, and CYGX could still be working on their other projects. Anyway, hope I'm right. Take care.
